141 related articles for article (PubMed ID: 21636650)
41. Nicotine enhances the thickness of biofilm and adherence of Candida albicans ATCC 14053 and Candida parapsilosis ATCC 22019.
Gunasegar S; Himratul-Aznita WH
FEMS Yeast Res; 2019 Mar; 19(2):. PubMed ID: 30476044
[TBL] [Abstract][Full Text] [Related]
42. Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species.
Bandara HMHN; Lam OLT; Watt RM; Jin LJ; Samaranayake LP
J Med Microbiol; 2010 Oct; 59(Pt 10):1225-1234. PubMed ID: 20576747
[TBL] [Abstract][Full Text] [Related]
43. [Determination of biofilm forming activity of microorganisms on synthetic polymeric materials.].
Godovalov AP; Stepanov MS; Yakovlev MV; Kobzarenko EE; Batog KA
Klin Lab Diagn; 2019; 64(12):758-761. PubMed ID: 32040901
[TBL] [Abstract][Full Text] [Related]
44. Biofilm characterization of Fusarium solani keratitis isolate: increased resistance to antifungals and UV light.
Córdova-Alcántara IM; Venegas-Cortés DL; Martínez-Rivera MÁ; Pérez NO; Rodriguez-Tovar AV
J Microbiol; 2019 Jun; 57(6):485-497. PubMed ID: 31134579
[TBL] [Abstract][Full Text] [Related]
45. Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components.
Bouchara JP; Oumeziane NA; Lissitzky JC; Larcher G; Tronchin G; Chabasse D
Eur J Cell Biol; 1996 May; 70(1):76-83. PubMed ID: 8738422
[TBL] [Abstract][Full Text] [Related]
46. Highlights in pathogenic fungal biofilms.
Sardi Jde C; Pitangui Nde S; Rodríguez-Arellanes G; Taylor ML; Fusco-Almeida AM; Mendes-Giannini MJ
Rev Iberoam Micol; 2014; 31(1):22-9. PubMed ID: 24252828
[TBL] [Abstract][Full Text] [Related]
47. Planktonic replication is essential for biofilm formation by Legionella pneumophila in a complex medium under static and dynamic flow conditions.
Mampel J; Spirig T; Weber SS; Haagensen JA; Molin S; Hilbi H
Appl Environ Microbiol; 2006 Apr; 72(4):2885-95. PubMed ID: 16597995
[TBL] [Abstract][Full Text] [Related]
48. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device.
Parahitiyawa NB; Samaranayake YH; Samaranayake LP; Ye J; Tsang PW; Cheung BP; Yau JY; Yeung SK
APMIS; 2006 Apr; 114(4):298-306. PubMed ID: 16689830
[TBL] [Abstract][Full Text] [Related]
49. Glass surface as potential in vitro substratum for Candida famata biofilm.
Malm A; Chudzik B; Piersiak T; Gawron A
Ann Agric Environ Med; 2010; 17(1):115-8. PubMed ID: 20684488
[TBL] [Abstract][Full Text] [Related]
50. Filamentous fungal biofilm for production of human drug metabolites.
Amadio J; Casey E; Murphy CD
Appl Microbiol Biotechnol; 2013 Jul; 97(13):5955-63. PubMed ID: 23515836
[TBL] [Abstract][Full Text] [Related]
51. Candida albicans biofilm-defective mutants.
Richard ML; Nobile CJ; Bruno VM; Mitchell AP
Eukaryot Cell; 2005 Aug; 4(8):1493-502. PubMed ID: 16087754
[TBL] [Abstract][Full Text] [Related]
52. In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
Narreddy S; Manavathu E; Chandrasekar PH; Alangaden GJ; Revankar SG
J Antimicrob Chemother; 2010 Apr; 65(4):701-3. PubMed ID: 20130026
[TBL] [Abstract][Full Text] [Related]
53. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method.
Singh J; Rimek D; Kappe R
Mycoses; 2005 Jul; 48(4):246-50. PubMed ID: 15982206
[TBL] [Abstract][Full Text] [Related]
54. Exopolysaccharide analysis of biofilm-forming Candida albicans.
Lal P; Sharma D; Pruthi P; Pruthi V
J Appl Microbiol; 2010 Jul; 109(1):128-36. PubMed ID: 20002865
[TBL] [Abstract][Full Text] [Related]
55. Proteome analysis of biofilm produced by a Fusarium falciforme keratitis infectious agent.
Calvillo-Medina RP; Reyes-Grajeda JP; Barba-Escoto L; Bautista-Hernandez LA; Campos-Guillén J; Jones GH; Bautista-de Lucio VM
Microb Pathog; 2019 May; 130():232-241. PubMed ID: 30851361
[TBL] [Abstract][Full Text] [Related]
56. Disruption of fungal and bacterial biofilms by lauroyl glucose.
Dusane DH; Rajput JK; Kumar AR; Nancharaiah YV; Venugopalan VP; Zinjarde SS
Lett Appl Microbiol; 2008 Nov; 47(5):374-9. PubMed ID: 19146524
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
Spreghini E; Orlando F; Giannini D; Barchiesi F
J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
[TBL] [Abstract][Full Text] [Related]
58. Development of
Lee HS; Kim Y
J Microbiol Biotechnol; 2018 Mar; 28(3):482-490. PubMed ID: 29316739
[No Abstract] [Full Text] [Related]
59. Microscopy of fungal biofilms.
Lagree K; Desai JV; Finkel JS; Lanni F
Curr Opin Microbiol; 2018 Jun; 43():100-107. PubMed ID: 29414442
[TBL] [Abstract][Full Text] [Related]
60. Morphological patterns of Aspergillus niger biofilms and pellets related to lignocellulolytic enzyme productivities.
Villena GK; Gutiérrez-Correa M
Lett Appl Microbiol; 2007 Sep; 45(3):231-7. PubMed ID: 17718832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
